Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 2.1 Exhibit 2.1
- 2.2 Exhibit 2.2
- 3.1 Exhibit 3.1
- 4.1 Exhibit 4.1
- 4.1.1 Exhibit 4.1.1
- 4.3 Exhibit 4.3
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.11.1 Exhibit 10.11.1
- 10.11.2 Exhibit 10.11.2
- 10.11.3 Exhibit 10.11.3
- 10.11.4 Exhibit 10.11.4
- 10.11.5 Exhibit 10.11.5
- 10.11.6 Exhibit 10.11.6
- 10.11.7 Exhibit 10.11.7
- 10.11.8 Exhibit 10.11.8
- 10.11.9 Exhibit 10.11.9
- 10.11.10 Exhibit 10.11.10
- 10.12.1 Exhibit 10.12.1
- 10.12.2 Exhibit 10.12.2
- 10.12.3 Exhibit 10.12.3
- 10.12.4 Exhibit 10.12.4
- 10.12.5 Exhibit 10.12.5
- 10.13 Exhibit 10.13
- 16.1 Exhibit 16.1
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
AMYT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated April 20, 2020 with respect to the consolidated financial statements of Amryt Pharma Plc included in the Registration Statement on Form F-1. We consent to the use of the aforementioned report in the Registration Statement on Form F-1 and to the use of our name as it appears under the caption “Experts”.
/s/ Grant Thornton
Dublin, Ireland
June 23, 2020